C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 239/94 (2006.01) A61K 31/517 (2006.01) A61K 31/5377 (2006.01) A61K 31/551 (2006.01) A61P 9/10 (2006.01) A61P 17/06 (2006.01) A61P 35/00 (2006.01) A61P 43/00 (2006.01) C07D 401/06 (2006.01) C07D 401/12 (2006.01) C07D 405/06 (2006.01)
Patent
CA 2442742
Compounds represented by the following general formula (I): (I) pharmaceutically acceptable salts thereof, hydrates or solvates of the same or mixtures of optically active isomers, racemic compounds or diastereomers of the same which have an excellent protein kinase inhibitory activity specific to tyrosine and, therefore, are usable as drugs, in particular, remedies/preventives for various cancers, diseases caused by arteriosclerosis or psoriasis.
L'invention concerne des composés représentés par la formule générale (I), des sels pharmaceutiquement acceptables de ces composés, des hydrates ou des solvates desdits composés ou des mélanges d'isomères optiquement actifs, de composés racémiques ou de diastéréomères desdits composés qui présentent une excellente activité d'inhibition des protéines kinases spécifique à la tyrosine et, de ce fait, peuvent être utilisés comme médicaments, en particulier en traitement/prévention de divers cancers, d'affections liées à l'artériosclérose ou du psoriasis.
Abe Daisuke
Kawahara Eiji
Kitano Yasunori
Nakajou Masahiro
Suzuki Tsuyoshi
Johnston Wassenaar Llp
Mitsubishi Pharma Corporation
Mitsubishi Tanabe Pharma Corporation
LandOfFree
Quinazoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinazoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazoline derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1992379